Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 0378-6333

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 0378-6333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acamprosate Calcium Structural Formula (5bf6f9a0 C65b 4301 B599 653fac1b60c2 01)

Chemical structure of acamprosate calcium, showing the molecular arrangement including acetyl, amide, propyl, and sulfonate groups complexed with a calcium ion (Ca2+).*

FDA Label Image

Acamprosate Calcium Delayed-release Tablets 333 mg Bottle Label (Image 01)

Label for Acamprosate Calcium Delayed-Release Tablets 333 mg by Mylan Pharmaceuticals Inc. The oral prescription drug comes in a container of 180 delayed-release tablets. The label includes dosage information, storage instructions (20° to 25°C), manufacturer location (Morgantown, WV), and indicates the product is made in India. It also features barcodes, a QR code, and regulatory codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.